Jessica Oliver
Psychiatric/Mental Health · Thomasville, GANPI 1114585940
Payments from drug & device makers
Across 893 payments — averaging $261.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$95K
- Axsome Therapeutics, Inc.$88K
- Neurocrine Biosciences, Inc.$44K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- Teva Pharmaceuticals USA, Inc.$1K
- Otsuka America Pharmaceutical, Inc.$860
- plus $3K from 14 others
What the payments were for
- Consulting fees$26,68811%
- Speaking & faculty fees$170,45473%
- Travel & lodging$20,2509%
- Food & beverage$15,8417%
- Education$490%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 286 | $94,924 |
| Axsome Therapeutics, Inc. | 185 | $88,054 |
| Neurocrine Biosciences, Inc. | 101 | $43,800 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 75 | $1,260 |
| Teva Pharmaceuticals USA, Inc. | 62 | $1,225 |
| Otsuka America Pharmaceutical, Inc. | 50 | $860 |
| Johnson & Johnson | 32 | $758 |
| Vanda Pharmaceuticals Inc. | 28 | $756 |
| E.r. Squibb & Sons, L.L.C. | 20 | $542 |
| Alkermes, Inc. | 22 | $440 |
| Lundbeck LLC | 10 | $216 |
| Indivior Inc. | 4 | $102 |
| Sunovion Pharmaceuticals Inc. | 4 | $76 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $68 |
| Corium, LLC | 3 | $57 |
| Ironshore Pharmaceuticals Inc. | 2 | $48 |
| Almatica Pharma LLC | 2 | $39 |
| Supernus Pharmaceuticals, Inc. | 1 | $21 |
| Eisai Inc. | 1 | $20 |
| Bausch Health US, LLC | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$90,022
- Auvelity$85,039
- INGREZZA$41,745
- COBENFY$237
- INVEGA SUSTENNA$125
- Austedo XR$125
- Fanapt$124
How this compares
$233,281 in reported general payments places this provider in the 95th percentile of 900 psychiatric/mental health providers in Georgia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 35 | $310,321 |
| VraylarCariprazine Hcl | 114 | $173,765 |
| Invega SustennaPaliperidone Palmitate | 35 | $122,240 |
| CaplytaLumateperone Tosylate | 43 | $76,920 |
| AuvelityDextromethorphan Hbr/Bupropion | 11 | $13,184 |
| Trazodone Hcl | 140 | $2,950 |
| Aripiprazole | 57 | $2,667 |
| Hydroxyzine Pamoate | 162 | $2,484 |
| Oxcarbazepine | 64 | $2,455 |
| Divalproex Sodium | 86 | $2,237 |
| Ziprasidone Hcl | 50 | $2,210 |
| Quetiapine Fumarate | 116 | $1,633 |
| Prazosin Hcl | 47 | $1,561 |
| Buspirone Hcl | 85 | $1,325 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 68 | $1,148 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $43,800 | $310,32135 claims |
| AbbVieVraylar | $94,924 | $173,765114 claims |
| Johnson & JohnsonInvega Sustenna | $758 | $122,24035 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $1,260 | $76,92043 claims |
| Axsome Therapeutics, Inc.Auvelity | $88,054 | $13,18411 claims |
| Almatica Pharma LLCSertraline Hcl | $39 | $69567 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 900 psychiatric/mental health providers in Georgia.
Other psychiatric/mental health in Thomasville
- Phyillis Kennedy-HowellBarney$673K
- Sherri KrollBrunswick$155K
- Taylor LeblancAlbany$48K
- Greta HeckmannDalton$28K
- Matthew DowdyWoodstock$25K
- Natasha GilesLoganville$21K
- Darrick SealeyWarner Robins$17K
- Olufunke AdewunmiSmyrna$13K
- Bradley MosherSuwanee$13K
- Mia MisonSuwanee$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.